Moderna Slammed By 'Fear, Confusion' After FDA Alleges Covid Shots Killed 10
Moderna and other vaccine stocks tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed 10 children.
| Ticker |
DVAX
|
| CIK | 0001029142 |
| SIC | 2834 |
| Sector | Manufacturing |
| Industry Category | Pharmaceutical Products |
| Industry Group | Pharmaceutical Preparations |
| Address | 2100 POWELL STREET, SUITE 720, EMERYVILLE, CA, 94608 |
| Website | dynavax.com |
| Phone | 5108485100 |
| CEO | Ryan Spencer |
| Employees | 350 |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Moderna Slammed By 'Fear, Confusion' After FDA Alleges Covid Shots Killed 10Moderna and other vaccine stocks tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed 10 children. Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 DeathsModerna and other vaccine stocks tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed 10 children. Exploring 3 High Growth Tech Stocks in the US MarketAs the U.S. market kicks off a holiday-shortened week with significant gains, investors are buoyed by optimism around potential Federal Reserve rate cuts and a rally in tech stocks, particularly those related to artificial intelligence. In this environment of heightened market activity and shifting economic indicators, identifying high-growth tech stocks requires a keen understanding of innovation trends and the ability to navigate volatility effectively. Dynavax to Participate at the 8th Annual Evercore Healthcare ConferenceDynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2nd at 2:10 p.m. ET. Why Dynavax Technologies (DVAX) Is Up 5.7% After Launching a $100 Million Buyback and Raising GuidanceDynavax Technologies announced in the past week that it will repurchase up to US$100 million of its common stock, reaffirmed its full-year 2025 guidance for HEPLISAV-B net product revenue at US$315 million to US$325 million, and reported improved third-quarter earnings with year-over-year growth in both revenues and net income. Alongside higher quarterly profits, the launch of the share repurchase program indicates the company's confidence in its financial position and future prospects. Now,... |